U.S., Oct. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07862335) titled 'Evaluating Autologous Platelet-Rich Fibrin Plasma for Chronic Lower Extremity Ulcers' on Oct. 01.
Brief Summary: To prospectively evaluate the safety and efficacy of an Autologous Platelet-Rich Fibrin Plasma system when applied in conjunction with Standard of Care for management of chronic lower extremity wounds.
Study Start Date: Sept., 2026
Study Type: INTERVENTIONAL
Condition:
Lower Extremity
Chronic Ulcers
Pressure Ulcer (PU)
Venous Leg Ulcer (VLU)
Wound Management
Intervention:
DEVICE: PRFM
Participants will receive weekly applications of PRFM and Standard of Care until ulcer closure, or a maximum of 20 weeks, whichever o...